Non-covalent Siglec-binding nanoparticles improve ligand stability and enable receptor-mediated delivery of therapeutic agents to target cells.
Controlled aqueous extraction and phytochemical markers make Astragalus preparations more consistent for immune modulation with lower inflammation and oxidative stress.
A water-based blend of tannic acid, surfactants, and essential oils denatures airborne allergens without flammable alcohol risks.
Selective spirocyclohexane Mcl-1 inhibitors strengthen target binding and restore apoptosis in cancers and other diseases with deregulated cell survival.
Sequence-specific siRNA duplexes degrade CFB mRNA to lower CFB protein levels and modulate complement-driven disease pathways.
Intermediate 2′FL and LNnT levels in infant formula reduce allergic sensitization while avoiding excessive HMO dosing and added formulation complexity.